Who owns Mirum Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MIRM from SEC Form 13F filings across 327 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 327 institutions disclosed 71.4M shares of Mirum Pharmaceuticals, Inc. worth $8.36B — about 112.7% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
327
13F holders
$8.36B
value, 2026 filers
112.7%
of shares outstanding (71.4M sh)
62
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MIRM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P. | 7.7M | $899.1M | 19.6% | 12.1% | 0.0% |
| 2 | Jupiter Topco LLCNEW | 5.9M | $691.7M | 0.3% | 9.3% | new |
| 3 | BlackRock, Inc. | 4.4M | $513.9M | 0.0% | 6.9% | +14.1% |
| 4 | FMR LLC | 3.7M | $429.7M | 0.0% | 5.8% | +86.7% |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.7M | $310.9M | 0.0% | 4.2% | +54.6% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $278.3M | 0.0% | 3.8% | +66.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.3M | $263.9M | 0.0% | 3.6% | -6.7% |
| 8 | STATE STREET CORP | 2.2M | $254.1M | 0.0% | 3.4% | +11.6% |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.4M | $164.5M | 0.5% | 2.2% | +318.5% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.4M | $163.2M | 0.0% | 2.2% | +10.6% |
| 11 | Invesco Ltd. | 1.4M | $159.7M | 0.0% | 2.2% | +378.2% |
| 12 | WELLINGTON MANAGEMENT GROUP LLP | 1.3M | $153.4M | 0.0% | 2.1% | -1.9% |
| 13 | EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | $146.2M | 2.0% | 2% | -11.4% |
| 14 | TANG CAPITAL MANAGEMENT LLC | 1.2M | $144.7M | 6.6% | 2% | 0.0% |
| 15 | Capital World Investors | 1.2M | $135.0M | 0.0% | 1.8% | +59.2% |
| 16 | FRANKLIN RESOURCES INC | 1.2M | $135.0M | 0.0% | 1.8% | +61.3% |
| 17 | NOVO HOLDINGS A/S | 1.1M | $131.7M | 7.6% | 1.8% | -15.1% |
| 18 | TCG Crossover Management, LLC | 1.1M | $124.3M | 3.0% | 1.7% | 0.0% |
| 19 | BVF INC/IL | 1.1M | $123.6M | 3.2% | 1.7% | -33.4% |
| 20 | Polar Capital Holdings Plc | 845,524 | $99.0M | 0.2% | 1.3% | +198.3% |
| 21 | Rock Springs Capital Management LP | 798,145 | $93.4M | 4.6% | 1.3% | -1.6% |
| 22 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 752,044 | $88.0M | 0.1% | 1.2% | +85.5% |
| 23 | AMERIPRISE FINANCIAL INC | 726,694 | $85.1M | 0.0% | 1.1% | +231.4% |
| 24 | TWO SIGMA INVESTMENTS, LP | 690,318 | $80.8M | 0.1% | 1.1% | -10.9% |
| 25 | Bank of New York Mellon Corp | 669,974 | $78.4M | 0.0% | 1.1% | +14.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.